Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yashaswini Singh

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
AMA Journal of Ethics|May 2, 2025
How Should We Stop Private Equity Firms From Exploiting Public Health Insurance?Yashaswini Singh
The New England Journal of Medicine|November 3, 2025
The Antitrust Antidote to Hospital and Nursing Home Corporatization - Promises and PitfallsYashaswini Singh
Health Services Research|November 26, 2025
Financialization and the Fragility of Maternal Health AccessYashaswini Singh
Circulation. Cardiovascular Quality and Outcomes|September 29, 2025
Association Between Market-Level Characteristics and Cardiologists Acquired by Private Equity in the United StatesHamid Torabzadeh, Yashaswini Singh
AJR. American Journal of Roentgenology|March 5, 2025
Private Equity Acquisitions of Radiology Practices From 2013 to 2023: National- and State-Level AnalysesMihir Khunte, Yashaswini Singh
JAMA Health Forum|June 14, 2024
Trends in Private Equity Consolidation in Cardiovascular CareYashaswini Singh, Megha Reddy, Christopher Whaley
The Journal of the American Academy of Orthopaedic Surgeons|October 15, 2025
Trends in Private Equity Acquisition of US Physical Therapy Clinics, 2010 to 2024Megha Reddy, Grace Li, Yashaswini Singh
The New England Journal of Medicine|February 10, 2025
The Rise of Private Equity in Health Care - Not a Uniquely American PhenomenonYashaswini Singh, Erin Fuse Brown, Irene Papanicolas
JAMA Health Forum|October 6, 2022
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular DiseaseMatthew D Eisenberg, Yashaswini Singh, Neeraj Sood
JAMA Network Open|March 14, 2023
Factors Associated With Public Trust in Pharmaceutical ManufacturersYashaswini Singh, Matthew D Eisenberg, Neeraj Sood
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
AMA Journal of Ethics|May 2, 2025
How Should We Stop Private Equity Firms From Exploiting Public Health Insurance?Yashaswini Singh
The New England Journal of Medicine|November 3, 2025
The Antitrust Antidote to Hospital and Nursing Home Corporatization - Promises and PitfallsYashaswini Singh
Health Services Research|November 26, 2025
Financialization and the Fragility of Maternal Health AccessYashaswini Singh
Circulation. Cardiovascular Quality and Outcomes|September 29, 2025
Association Between Market-Level Characteristics and Cardiologists Acquired by Private Equity in the United StatesHamid Torabzadeh, Yashaswini Singh
AJR. American Journal of Roentgenology|March 5, 2025
Private Equity Acquisitions of Radiology Practices From 2013 to 2023: National- and State-Level AnalysesMihir Khunte, Yashaswini Singh
JAMA Health Forum|June 14, 2024
Trends in Private Equity Consolidation in Cardiovascular CareYashaswini Singh, Megha Reddy, Christopher Whaley
The Journal of the American Academy of Orthopaedic Surgeons|October 15, 2025
Trends in Private Equity Acquisition of US Physical Therapy Clinics, 2010 to 2024Megha Reddy, Grace Li, Yashaswini Singh
The New England Journal of Medicine|February 10, 2025
The Rise of Private Equity in Health Care - Not a Uniquely American PhenomenonYashaswini Singh, Erin Fuse Brown, Irene Papanicolas
JAMA Health Forum|October 6, 2022
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular DiseaseMatthew D Eisenberg, Yashaswini Singh, Neeraj Sood
JAMA Network Open|March 14, 2023
Factors Associated With Public Trust in Pharmaceutical ManufacturersYashaswini Singh, Matthew D Eisenberg, Neeraj Sood
Pageof 4